Skip to main content

Table 1 Baseline characteristics of included patients in the in vivo study, Dabola

From: Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

Characteristics

 

AS/AQ (n = 110)

AS/SP (n = 110)

p

Gender ratio

M/F

54/56

0.96

51/59

0.86

0.16

Age (months)

Mean (SD)

29.5 (14.9)

28.7 (12.9)

0.68

Middle-upper arm circumference (mm)

Mean (SD)

149.2 (12.5)

147.6 (10.8)

0.29

Axillary temperature (°C)

Median (IQR)

39.0 (37.8–39.8)

39.1 (38.1–40.0)

0.46

Haemoglobin (g/dL)

Mean (SD)

8.7 (2.0)

8.7 (1.9)

0.92

Asexual parasitaemia (/μL)

Geometric mean (IQR)

40,492

20,121–97,615

34,716

15,658–41,226

0.45

Gametocyte carriage

n (%)

95% CI

13 (11.8)

6.4 – 19.3

11 (10.0)

5.1 – 17.8

0.66

  1. SD: Standard deviation IQR: Inter-Quartile Range